Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
300 mg Cannabidiol
600 mg Cannabidiol
+1 more
Locations
1
United States
Johns Hopkins Behavioral Pharmacology Research Unit
Baltimore, Maryland, United States
Start Date
November 1, 2022
Primary Completion Date
December 1, 2026
Completion Date
February 1, 2027
Last Updated
January 7, 2026
NCT06372899
NCT06264154
NCT06543407
NCT05766553
NCT06534047
NCT06488443
Lead Sponsor
Johns Hopkins University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions